Classical Complement Pathway Inhibitor
DBCAT005657Therapeutic category
A DrugBank category of 1 drug. 1 of them is approved.
- Drugs
What you can answer from here — as of April 30, 2022
Which targets do Classical Complement Pathway Inhibitor share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account